Travere Therapeutics Inc
TVTXHealthcare|Biotechnology|USA
$56.60
-1.88 (-3.22%)
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (291)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Coughlin Timothy | Director | 2026-06-12 | SELL | 10,000 | $50.07 | $500.7K |
| Baynes Roy D. | Director | 2026-06-12 | SELL | 4,500 | $50 | $225K |
| Coughlin Timothy | Director | 2026-05-15 | SELL | 3,250 | $43.49 | $141.3K |
| ROTE WILLIAM E. | Chief Research Officer | 2026-05-06 | SELL | 2,763 | $43.95 | $121.4K |
| REED ELIZABETH E | Chief Legal Officer and GC | 2026-05-06 | SELL | 24,250 | $45.06 | $1092.7K |
| Inrig Jula | CHIEF MEDICAL OFFICER | 2026-05-06 | SELL | 22,485 | $45.15 | $1015.2K |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-05-06 | SELL | 22,500 | $43.95 | $988.9K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2026-05-06 | SELL | 2,491 | $46.31 | $115.4K |
| Baynes Roy D. | Director | 2026-05-05 | SELL | 4,500 | $46.65 | $209.9K |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | 2026-05-05 | SELL | 2,174 | $46.65 | $101.4K |
| Meckler Jeffrey A | Director | 2026-05-04 | SELL | 8,000 | $45 | $360K |
| Baynes Roy D. | Director | 2026-05-01 | SELL | 9,750 | $44.22 | $431.1K |
| ROTE WILLIAM E. | Chief Research Officer | 2026-04-22 | SELL | 9,100 | $39.09 | $355.7K |
| REED ELIZABETH E | Chief Legal Officer and GC | 2026-04-15 | SELL | 51,500 | $41.29 | $2126.4K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2026-04-15 | SELL | 8,327 | $41.91 | $349K |
| Inrig Jula | CHIEF MEDICAL OFFICER | 2026-04-15 | SELL | 8,233 | $42.01 | $345.9K |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-04-15 | SELL | 64,000 | $41.09 | $2629.8K |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2026-04-14 | SELL | 21,977 | $41.07 | $902.6K |
| LYONS GARY A | Director | 2026-04-14 | SELL | 8,000 | $41.07 | $328.6K |
| Baynes Roy D. | Director | 2026-04-14 | SELL | 32,750 | $41.29 | $1352.2K |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | 2026-04-14 | SELL | 7,215 | $41.93 | $302.5K |
| Baynes Roy D. | Director | 2026-04-06 | SELL | 10,000 | $33 | $330K |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-04-01 | SELL | 60,000 | $30.93 | $1855.8K |
| REED ELIZABETH E | Chief Legal Officer and GC | 2026-04-01 | SELL | 10,000 | $30 | $300K |
| REED ELIZABETH E | Chief Legal Officer and GC | 2026-03-16 | SELL | 10,000 | $28.09 | $280.9K |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-02-20 | SELL | 60,000 | $30.1 | $1806K |
| REED ELIZABETH E | Chief Legal Officer and GC | 2026-02-17 | SELL | 10,000 | $27.83 | $278.3K |
| Inrig Jula | CHIEF MEDICAL OFFICER | 2026-02-04 | SELL | 1,779 | $32.21 | $57.3K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2026-02-04 | SELL | 1,745 | $32.19 | $56.2K |
| REED ELIZABETH E | Chief Legal Officer and GC | 2026-02-04 | SELL | 2,994 | $32.18 | $96.3K |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-02-03 | SELL | 100,087 | $32.28 | $3230.8K |
| Inrig Jula | CHIEF MEDICAL OFFICER | 2026-02-03 | SELL | 6,956 | $32.12 | $223.4K |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2026-02-03 | SELL | 4,333 | $32.12 | $139.2K |
| REED ELIZABETH E | Chief Legal Officer and GC | 2026-02-03 | SELL | 7,175 | $32.12 | $230.5K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2026-02-03 | SELL | 7,242 | $32.12 | $232.6K |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | 2026-02-03 | SELL | 7,310 | $32.12 | $234.8K |
| ROTE WILLIAM E. | Chief Research Officer | 2026-02-03 | SELL | 12,446 | $32.87 | $409.1K |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-01-27 | SELL | 60,000 | $30.09 | $1805.4K |
| REED ELIZABETH E | Chief Legal Officer and GC | 2026-01-20 | SELL | 10,000 | $27.34 | $273.4K |
| Inrig Jula | CHIEF MEDICAL OFFICER | 2026-01-06 | SELL | 2,476 | $39.74 | $98.4K |
| ROTE WILLIAM E. | Chief Research Officer | 2025-12-24 | SELL | 60,000 | $40.1 | $2406K |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-12-24 | SELL | 4,980 | $40 | $199.2K |
| Inrig Jula | CHIEF MEDICAL OFFICER | 2025-12-24 | SELL | 15,000 | $42 | $630K |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-12-24 | SELL | 7,402 | $40 | $296.1K |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-12-15 | SELL | 2,910 | $36 | $104.8K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-12-01 | SELL | 20,000 | $35.01 | $700.2K |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-11-04 | SELL | 67,115 | $36 | $2416.1K |
| Coughlin Timothy | Director | 2025-10-31 | SELL | 18,000 | $35.03 | $630.5K |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-10-31 | SELL | 5,591 | $35 | $195.7K |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-10-29 | SELL | 120,000 | $30.32 | $3638.4K |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-10-28 | SELL | 2,662 | $30 | $79.9K |
| REED ELIZABETH E | Chief Legal Officer and GC | 2025-09-22 | SELL | 10,000 | $25 | $250K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-09-04 | SELL | 573 | $18.51 | $10.6K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-08-27 | SELL | 470 | $17.31 | $8.1K |
| Inrig Jula | CHIEF MEDICAL OFFICER | 2025-07-01 | SELL | 815 | $14.65 | $11.9K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-05-05 | SELL | 1,784 | $21.05 | $37.6K |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-05-05 | SELL | 18,924 | $21.05 | $398.4K |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-05-05 | SELL | 1,771 | $21.05 | $37.3K |
| ROTE WILLIAM E. | Chief Research Officer | 2025-05-05 | SELL | 3,198 | $21.05 | $67.3K |
| REED ELIZABETH E | Chief Legal Officer and GC | 2025-05-05 | SELL | 4,920 | $21.05 | $103.6K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-04-11 | SELL | 48 | $13.14 | $0.6K |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2025-02-12 | SELL | 5,200 | $23.53 | $122.4K |
| REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2025-02-12 | SELL | 8,000 | $23.53 | $188.2K |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-02-12 | SELL | 5,642 | $24.33 | $137.3K |
| Inrig Jula | CHIEF MEDICAL OFFICER | 2025-02-12 | SELL | 2,568 | $23.53 | $60.4K |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-02-11 | SELL | 54,244 | $25 | $1356.1K |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-02-11 | SELL | 11,375 | $24.04 | $273.5K |
| Baynes Roy D. | Director | 2025-02-06 | SELL | 10,000 | $22 | $220K |
| Inrig Jula | CHIEF MEDICAL OFFICER | 2025-02-04 | SELL | 5,273 | $20.12 | $106.1K |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2025-02-03 | SELL | 8,951 | $19.78 | $177.1K |
| REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2025-02-03 | SELL | 8,951 | $19.78 | $177.1K |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-02-03 | SELL | 50,691 | $20.21 | $1024.5K |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-02-03 | SELL | 5,166 | $20.12 | $103.9K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-02-03 | SELL | 5,192 | $20.12 | $104.5K |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-02-03 | SELL | 3,348 | $20.12 | $67.4K |
| Baynes Roy D. | Director | 2025-01-23 | SELL | 16,000 | $20 | $320K |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2025-01-22 | SELL | 2,437 | $19.46 | $47.4K |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-01-22 | SELL | 10,736 | $19.46 | $208.9K |
| REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2025-01-22 | SELL | 2,437 | $19.46 | $47.4K |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-01-22 | SELL | 1,584 | $18.94 | $30K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-01-22 | SELL | 865 | $18.94 | $16.4K |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-01-22 | SELL | 925 | $18.94 | $17.5K |
| Inrig Jula | CHIEF MEDICAL OFFICER | 2025-01-06 | SELL | 2,506 | $19.04 | $47.7K |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-12-26 | SELL | 15,000 | $17.22 | $258.3K |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-11-25 | SELL | 12,090 | $18.3 | $221.2K |
| LYONS GARY A | Director | 2024-10-04 | SELL | 40,000 | $14.73 | $589.2K |
| Meckler Jeffrey A | Director | 2024-09-30 | SELL | 40,000 | $14.06 | $562.4K |
| Inrig Jula | CHIEF MEDICAL OFFICER | 2024-09-10 | SELL | 684 | $12.98 | $8.9K |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2024-09-09 | SELL | 4,387 | $11.52 | $50.5K |
| REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2024-09-09 | SELL | 4,387 | $11.52 | $50.5K |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 2024-09-09 | SELL | 21,125 | $11.52 | $243.4K |
| Inrig Jula | CHIEF MEDICAL OFFICER | 2024-09-09 | SELL | 2,191 | $11.52 | $25.2K |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | 2024-09-09 | SELL | 2,191 | $11.52 | $25.2K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2024-09-09 | SELL | 2,490 | $11.52 | $28.7K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2024-09-04 | SELL | 514 | $9.51 | $4.9K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2024-04-11 | SELL | 54 | $6.74 | $0.4K |
| REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2024-01-23 | SELL | 2,062 | $8.96 | $18.5K |
| Dube Eric M | CHIEF EXECUTIVE OFFICER | 2024-01-23 | SELL | 7,873 | $8.96 | $70.5K |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2024-01-23 | SELL | 853 | $9.07 | $7.7K |
| ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2024-01-23 | SELL | 2,062 | $8.96 | $18.5K |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-01-23 | SELL | 910 | $9.07 | $8.3K |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | 2024-01-23 | SELL | 1,559 | $9.07 | $14.1K |
| Inrig Jula | Chief Medical Officer | 2024-01-04 | SELL | 2,509 | $9.43 | $23.7K |
| Heerma Peter | Chief Commercial Officer | 2023-10-03 | SELL | 3,091 | $8.25 | $25.5K |
| Dube Eric M | CEO | 2023-09-05 | SELL | 4,455 | $14.71 | $65.5K |
| Cline Christopher R. | CFO | 2023-09-05 | SELL | 457 | $14.71 | $6.7K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2023-09-05 | SELL | 1,815 | $14.71 | $26.7K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2023-09-05 | SELL | 1,815 | $14.71 | $26.7K |
| Calvin Sandra | SVP, Chief Accounting Officer | 2023-05-11 | SELL | 558 | $16.49 | $9.2K |
| Cline Christopher R. | CFO | 2023-05-10 | SELL | 455 | $16.59 | $7.5K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2023-05-10 | SELL | 825 | $16.59 | $13.7K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2023-05-10 | SELL | 825 | $16.59 | $13.7K |
| Cline Christopher R. | CFO | 2023-04-11 | SELL | 47 | $21.49 | $1K |
| Calvin Sandra | SVP, Chief Accounting Officer | 2023-02-02 | SELL | 2,031 | $21.87 | $44.4K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2023-02-01 | SELL | 2,590 | $22.25 | $57.6K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2023-02-01 | SELL | 2,590 | $22.25 | $57.6K |
| Heerma Peter | Chief Commercial Officer | 2023-02-01 | SELL | 1,779 | $21.75 | $38.7K |
| Cline Christopher R. | CFO | 2023-02-01 | SELL | 1,588 | $21.75 | $34.5K |
| Dube Eric M | CEO | 2023-02-01 | SELL | 8,196 | $22.25 | $182.4K |
| Calvin Sandra | SVP, Chief Accounting Officer | 2023-01-25 | SELL | 1,097 | $21.86 | $24K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2023-01-24 | SELL | 2,062 | $21.5 | $44.3K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2023-01-24 | SELL | 2,062 | $21.5 | $44.3K |
| Dube Eric M | CEO | 2023-01-24 | SELL | 6,442 | $21.5 | $138.5K |
| Cline Christopher R. | CFO | 2023-01-24 | SELL | 852 | $21.9 | $18.7K |
| Heerma Peter | Chief Commercial Officer | 2023-01-24 | SELL | 1,550 | $21.9 | $33.9K |
| Dube Eric M | CEO | 2023-01-05 | SELL | 5,625 | $20.75 | $116.7K |
| Inrig Jula | Chief Medical Officer | 2023-01-05 | SELL | 2,493 | $20.75 | $51.7K |
| Heerma Peter | Chief Commercial Officer | 2022-10-04 | SELL | 3,042 | $25.68 | $78.1K |
| Calvin Sandra | SVP, Chief Accounting Officer | 2022-09-13 | SELL | 349 | $28 | $9.8K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2022-05-12 | SELL | 1,950 | $21.51 | $41.9K |
| ASELAGE STEVE | Director | 2022-05-11 | SELL | 2,575 | $21.92 | $56.4K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2022-05-11 | SELL | 1,563 | $21.71 | $33.9K |
| Clague Laura | CFO | 2022-05-11 | SELL | 2,200 | $21.51 | $47.3K |
| Calvin Sandra | SVP, Chief Accounting Officer | 2022-05-11 | SELL | 881 | $21.72 | $19.1K |
| Dube Eric M | CEO | 2022-02-10 | SELL | 4,832 | $27.84 | $134.5K |
| Calvin Sandra | VP, Corp Controller and CAO | 2022-01-31 | SELL | 798 | $26.51 | $21.2K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2022-01-31 | SELL | 1,350 | $27.4 | $37K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2022-01-31 | SELL | 1,125 | $27.4 | $30.8K |
| Heerma Peter | Chief Commercial Officer | 2022-01-31 | SELL | 1,125 | $27.4 | $30.8K |
| Calvin Sandra | VP, Corp Controller and CAO | 2022-01-24 | SELL | 934 | $24.58 | $23K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2022-01-24 | SELL | 1,875 | $24.98 | $46.8K |
| Heerma Peter | Chief Commercial Officer | 2022-01-24 | SELL | 1,875 | $24.98 | $46.8K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2022-01-24 | SELL | 2,250 | $24.98 | $56.2K |
| Clague Laura | CFO | 2022-01-24 | SELL | 2,063 | $24.98 | $51.5K |
| Dube Eric M | CEO | 2022-01-24 | SELL | 7,873 | $24.98 | $196.7K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2022-01-11 | SELL | 5,000 | $27.4 | $137K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2022-01-11 | SELL | 2,500 | $27.4 | $68.5K |
| Clague Laura | CFO | 2022-01-11 | SELL | 7,500 | $27.4 | $205.5K |
| Dube Eric M | CEO | 2022-01-05 | SELL | 17,332 | $30.08 | $521.3K |
| ASELAGE STEVE | Director | 2021-11-16 | SELL | 31,800 | $29.39 | $934.6K |
| ASELAGE STEVE | Director | 2021-11-05 | SELL | 10,000 | $26.23 | $262.3K |
| ASELAGE STEVE | Director | 2021-11-02 | SELL | 8,500 | $29.69 | $252.4K |
| ASELAGE STEVE | Director | 2021-10-07 | SELL | 60,000 | $26.25 | $1575K |
| Heerma Peter | Chief Commercial Officer | 2021-08-17 | SELL | 1,407 | $17.12 | $24.1K |
| Dube Eric M | CEO | 2021-08-17 | SELL | 7,836 | $17.12 | $134.2K |
| Rosenberg Noah L. | Chief Medical Officer | 2021-08-17 | SELL | 1,407 | $17.12 | $24.1K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2021-08-17 | SELL | 1,407 | $17.12 | $24.1K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2021-08-17 | SELL | 1,407 | $17.12 | $24.1K |
| Clague Laura | CFO | 2021-08-17 | SELL | 1,407 | $17.12 | $24.1K |
| Rosenberg Noah L. | Chief Medical Officer | 2021-07-28 | SELL | 1,250 | $13.81 | $17.3K |
| Dube Eric M | CEO | 2021-06-02 | SELL | 9,562 | $14.62 | $139.8K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2021-05-12 | SELL | 3,125 | $19.3 | $60.3K |
| Rosenberg Noah L. | Chief Medical Officer | 2021-05-12 | SELL | 750 | $19.3 | $14.5K |
| ASELAGE STEVE | Director | 2021-04-16 | SELL | 10,000 | $26.23 | $262.3K |
| ASELAGE STEVE | Director | 2021-03-17 | SELL | 17,727 | $27.44 | $486.4K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2021-02-18 | SELL | 2,500 | $28.01 | $70K |
| Rosenberg Noah L. | Chief Medical Officer | 2021-02-08 | SELL | 2,250 | $31.5 | $70.9K |
| Heerma Peter | Chief Commercial Officer | 2021-02-08 | SELL | 2,250 | $31.5 | $70.9K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2021-02-08 | SELL | 4,500 | $31.5 | $141.8K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2021-02-08 | SELL | 4,500 | $31.5 | $141.8K |
| Clague Laura | CFO | 2021-02-08 | SELL | 4,500 | $31.5 | $141.8K |
| Dube Eric M | CEO | 2021-02-08 | SELL | 9,626 | $31.5 | $303.2K |
| Heerma Peter | Chief Commercial Officer | 2021-02-03 | SELL | 1,126 | $29.83 | $33.6K |
| Rosenberg Noah L. | Chief Medical Officer | 2021-02-03 | SELL | 1,813 | $28.91 | $52.4K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2021-02-03 | SELL | 3,625 | $28.91 | $104.8K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2021-02-03 | SELL | 3,175 | $28.91 | $91.8K |
| Clague Laura | CFO | 2021-02-03 | SELL | 3,625 | $28.91 | $104.8K |
| Dube Eric M | CEO | 2021-02-03 | SELL | 2,406 | $28.91 | $69.6K |
| Rosenberg Noah L. | Chief Medical Officer | 2021-02-02 | SELL | 1,813 | $30.75 | $55.7K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2021-02-02 | SELL | 3,625 | $30.75 | $111.5K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2021-02-02 | SELL | 3,175 | $30.75 | $97.6K |
| Dube Eric M | CEO | 2021-02-02 | SELL | 8,734 | $29.91 | $261.2K |
| Clague Laura | CFO | 2021-02-02 | SELL | 3,625 | $30.75 | $111.5K |
| ASELAGE STEVE | Director | 2021-02-02 | SELL | 25,000 | $30.75 | $768.8K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2021-01-06 | SELL | 1,376 | $26.83 | $36.9K |
| Dube Eric M | CEO | 2021-01-06 | SELL | 6,876 | $26.83 | $184.5K |
| ASELAGE STEVE | Director | 2020-12-15 | SELL | 5,549 | $26.02 | $144.4K |
| ASELAGE STEVE | Director | 2020-12-02 | SELL | 7,891 | $23.43 | $184.9K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2020-11-16 | SELL | 2,500 | $23.96 | $59.9K |
| Clague Laura | CFO | 2020-11-16 | SELL | 7,500 | $23.98 | $179.9K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2020-11-16 | SELL | 2,500 | $23.98 | $60K |
| Clague Laura | CFO | 2020-11-13 | SELL | 7,500 | $23.61 | $177.1K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2020-11-13 | SELL | 2,500 | $23.62 | $59.1K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2020-11-13 | SELL | 2,500 | $23.62 | $59.1K |
| ASELAGE STEVE | Director | 2020-11-06 | SELL | 23,125 | $22.81 | $527.5K |
| Heerma Peter | Chief Commercial Officer | 2020-10-05 | SELL | 4,376 | $19.13 | $83.7K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2020-09-23 | SELL | 1,500 | $18.48 | $27.7K |
| Rosenberg Noah L. | Chief Medical Officer | 2020-09-23 | SELL | 750 | $18.48 | $13.9K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2020-09-23 | SELL | 1,500 | $18.48 | $27.7K |
| Clague Laura | CFO | 2020-09-23 | SELL | 1,500 | $18.48 | $27.7K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2020-09-22 | SELL | 1,500 | $18.59 | $27.9K |
| Rosenberg Noah L. | Chief Medical Officer | 2020-09-22 | SELL | 750 | $18.59 | $13.9K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2020-09-22 | SELL | 1,500 | $18.59 | $27.9K |
| Clague Laura | CFO | 2020-09-22 | SELL | 1,500 | $18.59 | $27.9K |
| Dube Eric M | CEO | 2020-09-21 | SELL | 10,805 | $19.28 | $208.3K |
| ASELAGE STEVE | Director | 2020-08-05 | SELL | 2,500 | $19.68 | $49.2K |
| Rosenberg Noah L. | Chief Medical Officer | 2020-07-28 | SELL | 870 | $20.49 | $17.8K |
| ASELAGE STEVE | Director | 2020-06-25 | SELL | 10,000 | $20 | $200K |
| ASELAGE STEVE | Director | 2020-05-14 | SELL | 8,125 | $16 | $130K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2020-05-12 | SELL | 1,577 | $16.37 | $25.8K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2020-05-12 | SELL | 2,152 | $16.28 | $35K |
| Clague Laura | CFO | 2020-05-12 | SELL | 3,027 | $16.22 | $49.1K |
| Rosenberg Noah L. | Chief Medical Officer | 2020-05-12 | SELL | 527 | $16.98 | $8.9K |
| ASELAGE STEVE | Director | 2020-05-05 | SELL | 2,500 | $15.88 | $39.7K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2020-03-10 | SELL | 3,250 | $14.87 | $48.3K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2020-03-10 | SELL | 3,500 | $15.02 | $52.6K |
| Clague Laura | CFO | 2020-03-10 | SELL | 4,000 | $15.02 | $60.1K |
| Rosenberg Noah L. | Chief Medical Officer | 2020-03-05 | SELL | 1,790 | $15.36 | $27.5K |
| ASELAGE STEVE | Director | 2020-03-05 | SELL | 4,359 | $15.36 | $67K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2020-02-18 | SELL | 2,500 | $16.64 | $41.6K |
| ASELAGE STEVE | Director | 2020-02-05 | SELL | 2,500 | $16.62 | $41.6K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2020-01-08 | SELL | 1,500 | $14.54 | $21.8K |
| Dube Eric M | CEO | 2020-01-08 | SELL | 7,500 | $14.54 | $109.1K |
| ASELAGE STEVE | Director | 2019-11-29 | SELL | 5,000 | $13.91 | $69.6K |
| Rosenberg Noah L. | Chief Medical Officer | 2019-07-31 | SELL | 2,500 | $19.95 | $49.9K |
| McFarlane Neil F. | COO | 2019-05-16 | SELL | 1,968 | $18.25 | $35.9K |
| Clague Laura | CFO | 2019-05-16 | SELL | 2,500 | $18.25 | $45.6K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2019-05-15 | SELL | 1,625 | $17.77 | $28.9K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2019-05-15 | SELL | 1,050 | $17.73 | $18.6K |
| ASELAGE STEVE | Director | 2019-05-15 | SELL | 3,676 | $17.81 | $65.5K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2019-02-19 | SELL | 2,500 | $21.48 | $53.7K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2019-02-12 | SELL | 1,769 | $21.44 | $37.9K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2019-02-12 | SELL | 1,985 | $21.44 | $42.6K |
| Clague Laura | CFO | 2019-02-12 | SELL | 2,033 | $21.44 | $43.6K |
| ASELAGE STEVE | CEO | 2019-02-12 | SELL | 2,130 | $21.44 | $45.7K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2019-01-09 | SELL | 1,500 | $23.96 | $35.9K |
| ASELAGE STEVE | CEO | 2018-12-21 | SELL | 12,376 | $21.88 | $270.8K |
| Clague Laura | CFO | 2018-12-21 | SELL | 7,500 | $21.96 | $164.7K |
| McFarlane Neil F. | COO | 2018-12-20 | SELL | 11,125 | $22.32 | $248.3K |
| ASELAGE STEVE | CEO | 2018-12-07 | SELL | 10 | $24.04 | $0.2K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2018-11-15 | SELL | 5,000 | $24.03 | $120.2K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2018-11-15 | SELL | 5,000 | $24.03 | $120.2K |
| Clague Laura | CFO | 2018-11-15 | SELL | 7,500 | $24.02 | $180.2K |
| ASELAGE STEVE | CEO | 2018-11-15 | SELL | 11,100 | $24.03 | $266.7K |
| McFarlane Neil F. | COO | 2018-11-14 | SELL | 10,000 | $23.73 | $237.3K |
| ASELAGE STEVE | CEO | 2018-08-31 | SELL | 12,000 | $32 | $384K |
| ROTE WILLIAM E. | Senior Vice President, R&D | 2018-02-14 | SELL | 1,034 | $21.5 | $22.2K |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 2018-01-05 | SELL | 942 | $24.04 | $22.6K |
| McFarlane Neil F. | COO | 2017-08-16 | SELL | 1,378 | $22.5 | $31K |
| ASELAGE STEVE | CEO | 2016-11-22 | SELL | 8,200 | $21.12 | $173.2K |
| Shih Alvin | EVP of Research & Development | 2016-09-01 | SELL | 8,750 | $16.24 | $142.1K |
| Shih Alvin | EVP of Research & Development | 2016-06-01 | SELL | 8,750 | $17.75 | $155.3K |
| Meckler Jeffrey A | Director | 2016-03-04 | BUY | 5,000 | $15.31 | $76.6K |
| Meckler Jeffrey A | Director | 2016-03-03 | BUY | 10,000 | $14.45 | $144.5K |
| Shih Alvin | EVP of Research & Development | 2016-03-01 | SELL | 8,750 | $14.35 | $125.6K |
| Shih Alvin | EVP of Research & Development | 2015-12-09 | SELL | 8,750 | $20.83 | $182.3K |
| ASELAGE STEVE | CEO | 2015-11-10 | SELL | 60,000 | $18.75 | $1125K |
| VALEUR JENSEN MARGARET E | General Counsel | 2015-11-02 | SELL | 50,000 | $20.46 | $1023K |
| Shih Alvin | EVP of Research & Development | 2015-10-06 | SELL | 8,750 | $20.12 | $176.1K |
| Shih Alvin | EVP of Research & Development | 2015-06-26 | SELL | 27,916 | $32.7 | $912.9K |
| Plotkin Horacio | Chief Medical Officer | 2014-12-12 | SELL | 2,100 | $10.07 | $21.1K |
| Meckler Jeffrey A | Director | 2014-11-25 | BUY | 15,000 | $8.6 | $129K |
| Richardson Steven Gary | Director | 2014-11-21 | BUY | 6,100 | $8.38 | $51.1K |
| Shkreli Martin | Fmr Officer Dir 10% Sharehldr | 2014-11-21 | SELL | 1,172,000 | $8.84 | $10360.5K |
| ASELAGE STEVE | CEO | 2014-11-21 | BUY | 10,000 | $8.46 | $84.6K |
| Golding Cornelius E | Director | 2014-11-19 | BUY | 2,000 | $9 | $18K |
| Plotkin Horacio | Chief Medical Officer | 2014-11-17 | SELL | 8,333 | $9.43 | $78.6K |
| Shkreli Martin | CEO, 10% Owner | 2014-10-01 | SELL | 300,000 | $0.01 | $3K |
| Shkreli Martin | CEO, 10% Owner | 2014-09-30 | BUY | 4,000 | $9.42 | $37.7K |
| Shkreli Martin | CEO, 10% Owner | 2014-09-22 | BUY | 53,000 | $11.15 | $591K |
| Shkreli Martin | CEO, 10% Owner | 2014-09-17 | BUY | 6,000 | $11.46 | $68.8K |
| Shkreli Martin | CEO, 10% Owner | 2014-09-16 | BUY | 7,500 | $10.69 | $80.2K |
| Paley Jeffrey | Director | 2014-08-14 | SELL | 20,000 | $12.28 | $245.6K |
| Shkreli Martin | CEO, 10% Owner | 2014-05-30 | SELL | 292,400 | $15.14 | $4426.9K |
| Shkreli Martin | CEO, 10% Owner | 2014-04-04 | BUY | 8,000 | $19.64 | $157.1K |
| Shkreli Martin | CEO, 10% Owner | 2014-04-03 | BUY | 22,500 | $22.6 | $508.5K |
| Shkreli Martin | CEO, 10% Owner | 2014-04-02 | BUY | 10,800 | $22.28 | $240.6K |
| Shkreli Martin | CEO, 10% Owner | 2014-03-24 | BUY | 4,000 | $17.61 | $70.4K |
| Shkreli Martin | CEO, 10% Owner | 2014-03-20 | BUY | 5,000 | $17.97 | $89.9K |
| Shkreli Martin | CEO, 10% Owner | 2014-03-19 | BUY | 3,500 | $18.44 | $64.5K |
| Shkreli Martin | CEO, 10% Owner | 2014-03-14 | BUY | 4,000 | $17.36 | $69.4K |
| Shkreli Martin | CEO, 10% Owner | 2014-03-11 | BUY | 25,900 | $19.47 | $504.3K |
| Shkreli Martin | CEO, 10% Owner | 2014-03-10 | BUY | 10,700 | $19.32 | $206.7K |
| Shkreli Martin | CEO, 10% Owner | 2014-03-07 | BUY | 4,058 | $18.52 | $75.2K |
| Shkreli Martin | CEO, 10% Owner | 2014-03-05 | BUY | 4,000 | $18.48 | $73.9K |
| Shkreli Martin | CEO, 10% Owner | 2014-02-28 | BUY | 43,100 | $18.66 | $804.2K |
| Shkreli Martin | CEO, 10% Owner | 2014-02-21 | BUY | 1,600 | $17.56 | $28.1K |
| Shkreli Martin | CEO, 10% Owner | 2014-02-14 | BUY | 3,500 | $14.6 | $51.1K |
| Shkreli Martin | CEO, 10% Owner | 2014-02-06 | BUY | 2,000 | $9.92 | $19.8K |
| Shkreli Martin | CEO, 10% Owner | 2014-01-14 | BUY | 8,000 | $10.84 | $86.7K |
| Shkreli Martin | CEO, 10% Owner | 2013-09-12 | BUY | 5,556 | $4.5 | $25K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked